Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 5, 2018Annals of OncologyOpen Access

CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJørgen SmebyOslo University HospitalASAnita SveenOslo University HospitalMMMarianne A. MerokAkershus University Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Smeby et al. (2018) studied this question.

synapsesocial.com/papers/6ab46ef3fb9ef90e9903ed84https://doi.org/10.1093/annonc/mdy085
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report1995 · 937 citations
  2. 2Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study2001 · 204 citations
  3. 3CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers2017 · 49 citations
  4. 4Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies2017 · 269 citations
  5. 5Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication2013 · 451 citations